The recent identification of a STAT3-mediated miR-146b down-regulation in neutropenic T-LGLL patients emphasized the pathogenetic role of STAT3 activation in neutropenia development. This evidence concerns the gene STAT3 and T-cell large granular lymphocyte leukemia.